. "RIV/61989592:15110/13:33146879" . "Hor\u00E1k, Pavel" . . . "1211-3778" . "6"^^ . "CZ - \u010Cesk\u00E1 republika" . "2"^^ . . . "Mu\u017Esk\u00E1 osteopor\u00F3za"@cs . . "Male osteoporosis"@en . "teriparatide; strontium ranelate; bisphosphonates; testosterone; osteoporosis"@en . "Male osteoporosis"@en . . "Mu\u017Esk\u00E1 osteopor\u00F3za" . "4" . . . . "Mu\u017Esk\u00E1 osteopor\u00F3za"@cs . "[5DD77A47AACE]" . "Sk\u00E1celov\u00E1, Martina" . "Osteopor\u00F3za u mu\u017E\u016F je onemocn\u011Bn\u00EDm se vzr\u016Fstaj\u00EDc\u00ED incidenc\u00ED, s pom\u011Brn\u011B vysokou mortalitou spojenou s frakturami. Relativn\u011B \u010Dasto je sekund\u00E1rn\u00ED etiologie, zejm\u00E9na se na jej\u00EDm vzniku pod\u00EDl\u00ED deficit pohlavn\u00EDch hormon\u016F (testosteron, estradiol) \u010Di jin\u00E9 choroby nebo u\u017E\u00EDv\u00E1n\u00ED l\u00E9k\u016F. Sekund\u00E1rn\u00ED etiologie by v\u017Edy m\u011Bla b\u00FDt p\u0159ed zah\u00E1jen\u00EDm l\u00E9\u010Dby jednozna\u010Dn\u011B vylou\u010Dena. V prevenci a l\u00E9\u010Db\u011B hraje v\u00FDznamnou roli \u00FAprava faktor\u016F \u017Eivotn\u00EDho stylu (pohybov\u00E1 aktivita, kou\u0159en\u00ED, alkohol apod.) a dostate\u010Dn\u00E1 suplementace kalcia a vitaminu D. V l\u00E9\u010Db\u011B osteopor\u00F3zy u mu\u017E\u016F se v sou\u010Dasn\u00E9 dob\u011B pou\u017E\u00EDvaj\u00ED bisfosfon\u00E1ty, kter\u00E9 p\u0159i pravideln\u00E9m pod\u00E1v\u00E1n\u00ED zvy\u0161uj\u00ED BMD v oblasti bedern\u00ED p\u00E1te\u0159e a proxim\u00E1ln\u00EDho femuru a p\u0159isp\u00EDvaj\u00ED k redukci rizika osteoporotick\u00FDch zlomenin. V sou\u010Dasn\u00E9 dob\u011B je k l\u00E9\u010Db\u011B schv\u00E1len alendron\u00E1t, risendron\u00E1t a kyselina zoledronov\u00E1. Z dal\u0161\u00EDch prepar\u00E1t\u016F, kter\u00E9 prok\u00E1zaly \u00FA\u010Dinnost v l\u00E9\u010Db\u011B osteopor\u00F3zy u mu\u017E\u016F, se v sou\u010Dasn\u00E9 dob\u011B pou\u017E\u00EDv\u00E1 stroncium ranel\u00E1t a teriparatid." . "RIV/61989592:15110/13:33146879!RIV14-MSM-15110___" . "Mu\u017Esk\u00E1 osteopor\u00F3za" . "Osteopor\u00F3za u mu\u017E\u016F je onemocn\u011Bn\u00EDm se vzr\u016Fstaj\u00EDc\u00ED incidenc\u00ED, s pom\u011Brn\u011B vysokou mortalitou spojenou s frakturami. Relativn\u011B \u010Dasto je sekund\u00E1rn\u00ED etiologie, zejm\u00E9na se na jej\u00EDm vzniku pod\u00EDl\u00ED deficit pohlavn\u00EDch hormon\u016F (testosteron, estradiol) \u010Di jin\u00E9 choroby nebo u\u017E\u00EDv\u00E1n\u00ED l\u00E9k\u016F. Sekund\u00E1rn\u00ED etiologie by v\u017Edy m\u011Bla b\u00FDt p\u0159ed zah\u00E1jen\u00EDm l\u00E9\u010Dby jednozna\u010Dn\u011B vylou\u010Dena. V prevenci a l\u00E9\u010Db\u011B hraje v\u00FDznamnou roli \u00FAprava faktor\u016F \u017Eivotn\u00EDho stylu (pohybov\u00E1 aktivita, kou\u0159en\u00ED, alkohol apod.) a dostate\u010Dn\u00E1 suplementace kalcia a vitaminu D. V l\u00E9\u010Db\u011B osteopor\u00F3zy u mu\u017E\u016F se v sou\u010Dasn\u00E9 dob\u011B pou\u017E\u00EDvaj\u00ED bisfosfon\u00E1ty, kter\u00E9 p\u0159i pravideln\u00E9m pod\u00E1v\u00E1n\u00ED zvy\u0161uj\u00ED BMD v oblasti bedern\u00ED p\u00E1te\u0159e a proxim\u00E1ln\u00EDho femuru a p\u0159isp\u00EDvaj\u00ED k redukci rizika osteoporotick\u00FDch zlomenin. V sou\u010Dasn\u00E9 dob\u011B je k l\u00E9\u010Db\u011B schv\u00E1len alendron\u00E1t, risendron\u00E1t a kyselina zoledronov\u00E1. Z dal\u0161\u00EDch prepar\u00E1t\u016F, kter\u00E9 prok\u00E1zaly \u00FA\u010Dinnost v l\u00E9\u010Db\u011B osteopor\u00F3zy u mu\u017E\u016F, se v sou\u010Dasn\u00E9 dob\u011B pou\u017E\u00EDv\u00E1 stroncium ranel\u00E1t a teriparatid."@cs . "Osteologick\u00FD bulletin" . . "18" . . "I" . . "15110" . . "90275" . . . "Male osteoporosis is a condition with an increasing incidence and relatively high mortality associated with fractures. A secondary etiology is quite common, mostly contributed to by deficiency of sex hormones (testosterone, estradiol), other diseases and medication use. Prior to treatment intiation, a secondary etiology should be clearly ruled out. A significant role in the prevention and treatment is played by modification of lifestyle factors (physical activity, smoking, alcohol cunsumption, etc.) and sufficient calcium and vitamin D supplementation. In the treatment of male osteoporosis, bisphosphonates are currently used. If taken regularly, they increase BMD of the lumbar spine and proximal femur and aid in reducing the risk of osteoporotic fractures. Drugs currently approved for use are alendronate, risedronate and zoledronic acid. Other drugs known to be effective in the treatment of male osteoporosis are strontium ranelta and teriparatide."@en . . . "2"^^ .